Skip to main navigation Skip to search Skip to main content

Activation of big MAP kinase 1 (BMK1/ERK5) inhibits cardiac injury after myocardial ischemia and reperfusion

  • Scott J. Cameron
  • , Seigo Itoh
  • , Christopher P. Baines
  • , Changxi Zhang
  • , Shinsuke Ohta
  • , Wenyi Che
  • , Michael Glassman
  • , Jiing Dwan Lee
  • , Chen Yan
  • , Jay Yang
  • , Jun Ichi Abe

Research output: Contribution to journal › Article › peer-review

Abstract

Big MAP kinase 1 (BMK1/ERK5) plays a critical role in pre-natal development of the cardiovascular system and post-natal eccentric hypertrophy of the heart. Of the two isoforms upstream of MAPK-kinase 5 (MEK5) known to exist, only the longer MEK5α isoform potently activates BMK1. We generated cardiac-specific constitutively active form of the MEK5α (CA-MEK5α transgenic (Tg) mice), and observed a 3 to 4-fold increase in endogenous BMK1 activation and hyperphosphorylation of connexin 43 in the ventricles of the Tg compared to wild-type mice. The CA-MEK5α-Tg-mice demonstrated a profoundly accelerated recovery of left ventricular developed pressure after ischemia/reperfusion. We propose a novel role for BMK1 in protecting the heart from ischemia/reperfusion-induced cardiac injury.

Original languageEnglish (US)
Pages (from-to)255-260
Number of pages6
JournalFEBS Letters
Volume566
Issue number1-3
DOIs
StatePublished - May 21 2004
Externally publishedYes

Keywords

  • Big MAP kinase 1
  • Cardiac physiology
  • Hypoxia/reperfusion-injury
  • MAP kinase
  • MAPK-kinase 5
  • Transgenic

ASJC Scopus subject areas

  • Biophysics
  • Structural Biology
  • Biochemistry
  • Molecular Biology
  • Genetics
  • Cell Biology

Fingerprint

Dive into the research topics of 'Activation of big MAP kinase 1 (BMK1/ERK5) inhibits cardiac injury after myocardial ischemia and reperfusion'. Together they form a unique fingerprint.

Cite this